Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Parkinsonism: onset, progression and mortality.

× No keyword cloud information.

2000 in total

1. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.

Authors: M A Hely; J G Morris; R Traficante; W G Reid; D J O'Sullivan; P M Williamson
Journal: J Neurol Neurosurg Psychiatry Date: 1999-09 Impact factor: 10.154

2. Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease.

Authors: K Dujardin; A Duhamel; E Becquet; C Grunberg; L Defebvre; A Destee
Journal: J Neurol Neurosurg Psychiatry Date: 1999-09 Impact factor: 10.154

3. Patient preferences and utilities for 'off-time' outcomes in the treatment of Parkinson's disease.

Authors: C S Palmer; J K Schmier; E Snyder; B Scott
Journal: Qual Life Res Date: 2000 Impact factor: 4.147

4. Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease.

Authors: S Papapetropoulos; C Paschalis; A Athanassiadou; A Papadimitriou; J Ellul; M H Polymeropoulos; T Papapetropoulos
Journal: J Neurol Neurosurg Psychiatry Date: 2001-05 Impact factor: 10.154

Review 5. Bromocriptine for levodopa-induced motor complications in Parkinson's disease.

Authors: J J van Hilten; C Ramaker; W J Van de Beek; M J Finken
Journal: Cochrane Database Syst Rev Date: 2000

6. Health related quality of life in Parkinson's disease: a prospective longitudinal study.

Authors: K H Karlsen; E Tandberg; D Arsland; J P Larsen
Journal: J Neurol Neurosurg Psychiatry Date: 2000-11 Impact factor: 10.154

Review 7. Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors: R C Dodel; K Berger; W H Oertel
Journal: Pharmacoeconomics Date: 2001 Impact factor: 4.981

8. The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors: R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal: Pharmacoeconomics Date: 1998-09 Impact factor: 4.981

9. Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.

Authors: A Barbeau
Journal: Can Med Assoc J Date: 1975-06-21 Impact factor: 8.262

10. Discrete and dynamic scaling of the size of continuous graphic movements of parkinsonian patients and elderly controls.

Authors: M G Longstaff; P R Mahant; M A Stacy; A W A Van Gemmert; B C Leis; G E Stelmach
Journal: J Neurol Neurosurg Psychiatry Date: 2003-03 Impact factor: 10.154